Oxygen-glucose deprivation regulates BACE1 expression through induction of autophagy in Neuro-2a/APP695 cells
暂无分享,去创建一个
Ting Zhang | Xiao-Jiang Sun | Rong Chen | Yinyi Sun | Nan Shi | Yameng Sun | F. Shen | Yan Zhang | Wenqi Chen | Kang-Yong Liu
[1] Kshitiz,et al. Chaperone-mediated Autophagy Targets Hypoxia-inducible Factor-1α (HIF-1α) for Lysosomal Degradation* , 2013, The Journal of Biological Chemistry.
[2] R. Tanzi,et al. SUMO1 modulates Aβ generation via BACE1 accumulation , 2013, Neurobiology of Aging.
[3] A. Cavalli,et al. Computational methods in the discovery and design of BACE-1 inhibitors. , 2012, Current medicinal chemistry.
[4] S. Eketjäll,et al. New aminoimidazoles as beta-secretase (BACE-1) inhibitors showing amyloid-beta (A beta ) lowering in brain. , 2012 .
[5] S. Eketjäll,et al. New aminoimidazoles as β-secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain. , 2012, Journal of medicinal chemistry.
[6] M. Mintun,et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline , 2012, Annals of neurology.
[7] J. McLaurin,et al. Inhibition of amyloid-beta peptide aggregation rescues the autophagic deficits in the TgCRND8 mouse model of Alzheimer disease. , 2012, Biochimica et biophysica acta.
[8] S. Gandy,et al. Dynamin 1 Regulates Amyloid Generation through Modulation of BACE-1 , 2012, PloS one.
[9] S. Rivest,et al. The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease , 2012, The European journal of neuroscience.
[10] K. Kawahara,et al. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice , 2012, Neuroscience.
[11] J. Gronych,et al. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. , 2012, Cancer research.
[12] M. Masserini,et al. Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation , 2012, Molecular and Cellular Neuroscience.
[13] C. Rowe,et al. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition , 2012, Neurology.
[14] M. Mattson,et al. Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation , 2012, Nature Communications.
[15] Felicita Pedata,et al. Cognitive impairment with vascular impairment and degeneration. , 2011, Current neurovascular research.
[16] Smita Majumder,et al. Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits , 2011, Alzheimer's & Dementia.
[17] Ting Zhang,et al. 3-n-butylphthalide (NBP) attenuated neuronal autophagy and amyloid-beta expression in diabetic mice subjected to brain ischemia , 2011, Neurological research.
[18] D. Rubinsztein,et al. Regulation of mammalian autophagy in physiology and pathophysiology. , 2010, Physiological reviews.
[19] Rena Li,et al. Genetic Targeting Aromatase in Male Amyloid Precursor Protein Transgenic Mice Down-Regulates β-Secretase (BACE1) and Prevents Alzheimer-Like Pathology and Cognitive Impairment , 2010, The Journal of Neuroscience.
[20] Joseph V. Hajnal,et al. A robust method to estimate the intracranial volume across MRI field strengths (1.5T and 3T) , 2010, NeuroImage.
[21] G. Tsokos,et al. Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury , 2010, Journal of Neuroinflammation.
[22] J. Pouysségur,et al. Hypoxia-induced autophagy: cell death or cell survival? , 2010, Current opinion in cell biology.
[23] Jayanta Debnath,et al. Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease , 2010, PloS one.
[24] N. Mizushima,et al. Methods in Mammalian Autophagy Research , 2010, Cell.
[25] G. Semenza. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics , 2010, Oncogene.
[26] S. Pendlebury,et al. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis , 2009, The Lancet Neurology.
[27] Ralph A. Nixon,et al. Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[28] Daniel J. Klionsky,et al. Autophagy fights disease through cellular self-digestion , 2008, Nature.
[29] John L Cleveland,et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.
[30] Guido Kroemer,et al. Autophagy in the Pathogenesis of Disease , 2008, Cell.
[31] Manuel Buttini,et al. Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice* , 2007, Journal of Biological Chemistry.
[32] Jiankun Cui,et al. Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation* , 2007, Journal of Biological Chemistry.
[33] M. Ohno,et al. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice , 2007, Neurobiology of Disease.
[34] Hong Qing,et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression , 2006, Proceedings of the National Academy of Sciences.
[35] H. Cai,et al. BACE1, a Major Determinant of Selective Vulnerability of the Brain to Amyloid-β Amyloidogenesis, is Essential for Cognitive, Emotional, and Synaptic Functions , 2005, The Journal of Neuroscience.
[36] L. Tjernberg,et al. Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease , 2005, The Journal of cell biology.
[37] B. Hyman,et al. BACE Is Degraded via the Lysosomal Pathway* , 2005, Journal of Biological Chemistry.
[38] M. Ohno,et al. BACE1 Deficiency Rescues Memory Deficits and Cholinergic Dysfunction in a Mouse Model of Alzheimer's Disease , 2004, Neuron.
[39] D. Attaix,et al. Class III phosphoinositide 3-kinase--Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes. , 2003, The Biochemical journal.
[40] D. Leys,et al. Poststroke dementia , 2001, Neurology.
[41] R. Vassar. The beta-secretase, BACE: a prime drug target for Alzheimer's disease. , 2001, Journal of molecular neuroscience : MN.
[42] D. Small,et al. Regulation of APP cleavage by α‐, β‐ and γ‐secretases , 2000 .
[43] G. Semenza,et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.
[44] M. Moskowitz,et al. Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.
[45] V. Hachinski,et al. Cerebrovascular Pathology in Alzheimer's Disease: Cause, Effect or Epiphenomenon? , 1997, Annals of the New York Academy of Sciences.
[46] M. Goldberg,et al. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] Jiankun Cui,et al. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. , 2007, The Journal of biological chemistry.
[48] R. Vassar. beta-Secretase, APP and Abeta in Alzheimer's disease. , 2005, Sub-cellular biochemistry.
[49] R. Vassar. β-Secretase, APP and Aβ in Alzheimer’s Disease , 2005 .
[50] D. Small,et al. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. , 2000, FEBS letters.
[51] N. Saunders. Neural regeneration research , 1999 .
[52] D. Rubinsztein,et al. Regulation of Mammalian Autophagy in Physiology and Pathophysiology , 2022 .
[53] K. Blomgren,et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.